首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   315篇
  免费   20篇
  国内免费   13篇
耳鼻咽喉   146篇
儿科学   1篇
妇产科学   4篇
基础医学   25篇
口腔科学   1篇
临床医学   8篇
内科学   29篇
神经病学   5篇
特种医学   25篇
外科学   10篇
综合类   39篇
预防医学   6篇
眼科学   5篇
药学   13篇
中国医学   27篇
肿瘤学   4篇
  2023年   4篇
  2022年   6篇
  2021年   11篇
  2020年   9篇
  2019年   12篇
  2018年   14篇
  2017年   7篇
  2016年   3篇
  2015年   9篇
  2014年   16篇
  2013年   8篇
  2012年   24篇
  2011年   17篇
  2010年   16篇
  2009年   16篇
  2008年   14篇
  2007年   18篇
  2006年   30篇
  2005年   11篇
  2004年   25篇
  2003年   22篇
  2002年   20篇
  2001年   12篇
  2000年   8篇
  1999年   4篇
  1998年   5篇
  1997年   1篇
  1996年   1篇
  1995年   3篇
  1994年   2篇
排序方式: 共有348条查询结果,搜索用时 15 毫秒
1.
2.
Liu  Jing  Zhu  Qi  Han  Jing  Zhang  Hui  Li  Yuan  Ma  Yanyun  Ji  Hengdong  He  Dongyi  Gu  Jianxin  Zhou  Xiaodong  Reveille  John D.  Jin  Li  Zou  Hejian  Ren  Shifang  Wang  Jiucun 《Clinical rheumatology》2020,39(10):3159-3159
Clinical Rheumatology - In the original version of the above article the References 19 and 20 were incorrect which cannot describe the development of the SPARCC score.  相似文献   
3.
To analyze the spectrum and founder effect of TMC1 mutations in patients with non‐syndromic deafness in the Xiamen area. Sporadic pedigrees were detected by targeted next‐generation sequencing, and 110 unrelated patients from Xiamen Special Education School were analyzed through Sanger sequencing for the TMC1 gene. In total, 53 SNPs were designed to analyze the haplotypes of the TMC1 c.2050G>C mutation. The probands of three families were found to be homozygous for TMC1 c.2050G>C, and their parents were all heterozygous for the TMC1 c.2050G>C mutation. In 110 unrelated patients from Xiamen Special Education School, four were found to carry compound heterozygotes of TMC1 c.2050G>C, which were compound heterozygotes of c.804G>A, c.1127T>C, c.1165C>T, and c.1396_1398delAAC, respectively. Three types of TMC1 polymorphisms (c.45C>T, c.1713C>T, c.2208+49C>T) and two heterozygotes of novel variants (c.1764‐4C>A, c.2073G>A[p.K691K]) were found in the remaining 100 patients. In total, four novel variants were detected in this study. These mutations and variants were not detected in 100 normal samples. The haplotypes of the probands of families with TMC1 c.2050G>C were identical. There were unique hotspots and spectra of TMC1 mutations in the Xiamen deaf population. Haplotype analysis is useful to understand the founder effect of the hot spot mutation.  相似文献   
4.
目的探讨腰大池置管持续引流对动脉瘤性蛛网膜下腔出血(a SAH)并发脑积水的防治效果。方法选取86例a SAH急性期行动脉瘤夹闭手术患者随机分为两组:对照组患者术后仅行间断腰椎穿刺治疗,观察组患者则术后则行腰大池置管持续外引流治疗,并定期测定两组患者脑脊液中溶血磷脂酸(LPA)含量,观察其与a SAH并发脑积水的关系及临床安全性。结果 a SAH对照组患者发病7 d、14 d时脑脊液LPA含量显著高于观察组(t1=8.225,P=0.000;t2=4.168,P<0.001);a SAH对照组并发急性脑积水的发生率与观察组间无显著性差异(χ2=0.192,P=0.661),而a SAH对照组并发亚急性和慢性脑积水的发生率明显高于观察组(χ2=7.535,P=0.006);所有a SAH并发脑积水患者发病14 d时脑脊液中LPA含量显著高于a SAH未并发脑积水患者(t=4.893,P<0.001);治疗期间两组a SAH患者均未出现严重并发症。结论早期腰大池持续外引流能够有效防治a SAH并发脑积水的发生,该作用与其降低a SAH后脑脊液中LPA含量密切相关。  相似文献   
5.
Oral squamous cell carcinoma (OSCC) ranks as the fifth most common cancer worldwide with poor prognosis. Recently, tumor necrosis factor receptor-associated factor 4 (TRAF4) has attracted increasing attenuation due to its overexpression in certain cancers. However, its function and underlying mechanism in OSCC remains elusive. In this study, the high expression of TRAF4 mRNA and protein levels was noted in OSCC cell lines. Its overexpression with pcDNA3.1-TRAF4 vector transfection dramatically promoted cell proliferation and inhibited cell apoptosis, indicating a pivotal role of TRAF4 in OSCC cell growth. Simultaneously, TRAF4 elevation also increased cell invasion and migration. Mechanism analysis confirmed that TRAF4 up-regulation induced the expression of β-catenin and the downstream target molecules of cyclinD1, c-myc, Bcl-2, MMP-9 and MMP-2, indicating that TRAF4 could induce the activation of Wnt/β-catenin pathway. After pretreatment with β-catenin siRNA, the pathway was remarkably silenced. Simultaneously, cell growth, invasion and migration induced by TRAF4 were strikingly abrogated, suggesting that TRAF4 may promote OSCC cell growth, invasion and migration by Wnt/β-catenin pathway. Together, this study confirmed that TRAF4 acts as an oncogene for the development and progression of OSCC. Therefore, our study may support a promising therapeutic target for the treatment of OSCC.  相似文献   
6.
目的:评价支气管镜肺活检(transbronchial lung biopsy,TBLB)在肺泡蛋白沉积症(pulmonary alveolar proteinosis,PAP)中的诊断价值和限度。方法:对2006年6月至2012年12月在中南大学湘雅二医院住院、资料完整的 TBLB病理确诊和非TBLB诊断的PAP 25例及TBLB病理误诊为PAP 4例进行回顾性分析。结果:25例PAP患者中,14例 一次TBLB病理确诊[一次TBLB阳性率为56%(14/25)],一次TBLB阴性病例中6例再次TBLB确诊[二次TBLB阳性率为 24%(6/25)],总阳性率为80%(20/25),总阴性率为20%(5/25)。其中,5例经典型CT表现及支气管肺泡灌洗液检查确 诊,并经全肺灌洗证实;而同期TBLB病理检查将其他疾病误诊为PAP者4例。结论:TBLB是很好的诊断方法,但一 次TBLB阴性不能排除PAP,条件允许可重复进行;临床和CT表现典型结合肺泡灌洗液检查阳性可作为临床诊断依 据;不典型的病例需进行TBLB。  相似文献   
7.
Endothelial dysfunction is associated with major causes of morbidity and mortality, as well as numerous age-related conditions. The possibility of preserving or even rejuvenating endothelial function offers a potent means of preventing/treating some of the most fearful aspects of aging such as loss of mental, cardiovascular, and sexual function. Endothelial precursor cells (EPC) provide a continual source of replenishment for damaged or senescent blood vessels. In this review we discuss the biological relevance of circulating EPC in a variety of pathologies in order to build the case that these cells act as an endogenous mechanism of regeneration. Factors controlling EPC mobilization, migration, and function, as well as therapeutic interventions based on mobilization of EPC will be reviewed. We conclude by discussing several clinically-relevant approaches to EPC mobilization and provide preliminary data on a food supplement, Stem-Kine, which enhanced EPC mobilization in human subjects.  相似文献   
8.
The objective of this study was to systemically and comprehensively evaluate the associations between smoking and disease outcomes in patients with ankylosing spondylitis (AS). Information on smoking, clinical features, and sociodemographic characteristics was collected by a questionnaire administered directly to the patient. Group differences were analyzed by t test or chi-square test. Logistic regression analysis was conducted with the Bath AS Disease Activity Index (BASDAI), Bath AS Functional Index (BASFI), C-reactive protein, and erythrocyte sedimentation rate as the dependent variables and different stratification of smoking duration, smoking intensity, and cumulative smoking as independent variables. In order to compare our results with previous studies, meta-analysis was performed to calculate standardized mean difference (SMD) for relationship between outcomes and smoking status. A total of 1178 AS patients were analyzed. Compared with non-smokers, the risk of having active disease (BASDAI ≥?4) was higher in patients who smoked at least 15 years, or 15 cigarettes per day, or 15 pack-years (OR?=?1.70 [1.06, 2.73], 1.75 [1.08, 2.82], and 1.97 [1.06, 3.67], respectively); and smokers had increasing risk of BASDAI ≥?4 with increasing years of smoking, or cigarettes per day, or pack-years (p-trend?=?0.010, 0.008 and 0.006, respectively). The risk of having active disease was higher in patients who smoked at least 15 cigarettes per day or 15 pack-years (OR?=?1.74 [1.06, 2.84] and 2.89 [1.56, 5.35], respectively), with increasing number of cigarettes per day and pack-years. Smokers had an increased risk of BASFI ≥?4 (p-trend?=?0.040 and 0.007, respectively). By meta-analysis, current, former and ever smokers had significantly higher BASDAI (SMD?=?0.34 [0.18, 0.48], 0.10 [0.01, 0.19], and 0.27 [0.20, 0.34], respectively) and BASFI (SMD?=?0.35 [0.16, 0.55], 0.30 [0.22, 0.39], and 0.35 [0.21, 0.50], respectively) compared to non-smokers. Smoking is a risk factor for greater disease activity and worse functioning in AS patients.  相似文献   
9.
Su  Jinmei  Li  Mengtao  He  Lan  Zhao  Dongbao  Wan  Weiguo  Liu  Yi  Xu  Jianhua  Xu  Jian  Liu  Huaxiang  Jiang  Lindi  Wu  Huaxiang  Zuo  Xiaoxia  Huang  Cibo  Liu  Xiumei  Li  Fen  Zhang  Zhiyi  Liu  Xiangyuan  Dong  Lingli  Li  Tianwang  Chen  Haiying  Li  Jingyang  He  Dongyi  Lu  Xin  Huang  Anbin  Tao  Yi  Wang  Yanyan  Zhang  Zhuoli  Wei  Wei  Li  Xiaofeng  Zeng  Xiaofeng 《Clinical rheumatology》2022,41(3):731-739
Clinical Rheumatology - The equivalence of the biosimilar HS016 to adalimumab (Humira) for the treatment of active ankylosing spondylitis (AS) patients has been previously validated. The aim was to...  相似文献   
10.
目的 探讨脑卒中继发癫(癎)的临床特点及发生癫(癎)的影响因素,为临床防治提供依据.方法 回顾性分析2010-06-2012-06本院收治的76例(病例组)脑卒中后继发癫(癎)的患者资料,同时随机抽取神经内科住院的76例(对照组)未继发癫(癎)的脑卒中患者资料,分析脑卒中后癫(癎)的临床特点和相关危险因素.结果 脑卒中继发癫(癎)发生率7.7%(76/986),其中缺血性脑卒中82.9%,出血脑卒中17.1%;早发性癫(癎)25.0%,迟发性癫(癎)75.0%;皮质病灶继发癫((癎))69.7%,皮质下病灶继发癫((癎))30.3%.单因素分析显示,2组患者脑卒中类型、病灶部位与受累半球侧别等因素比较,差异均有统计学意义(P〈0.05);多因素分析显示,出血性脑卒中和皮质病灶差异有统计学意义(P〈0.05).结论 脑卒中继发癫(癎)以迟发性癫(癎)多见.出血性脑卒中和皮质病灶是脑卒中继发癫(癎)的独立危险因素.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号